Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Apr 13;181(2):309–322. doi: 10.1007/s10549-020-05630-5

Figure 5.

Figure 5

Association of lymphovascular invasion (LVI) with immune characteristics of primary tumors of a TCGA-BRCA and b validation cohorts. Tukey boxplots of values for relative fractions of tumor-infiltrating immune cells of different types, tumor immune cytolytic activity, and B (BCR) and T cell receptor (TCR) diversity in the tumor microenvironment are shown for the LVI-positive and -negative cases of the two cohorts, respectively. Measurements of some features were unavailable for the validation cohort. The p values in two-group comparisons were calculated with standard t test. NK, natural killer.